Eloxx PharmaceuticalsELOX +5.57%17 Market Cap is $41.39 Mil as of Jun. 27, 2026. GuruFocus rates ELOX with a GF Score™ of 17/100. The stock has 1 warning sign investors should review. Among 1,431 Biotechnology companies, Eloxx Pharmaceuticals ranks worse than 67.09% on this metric.
Eloxx Pharmaceuticals's quarterly market cap
declined
from Dec. 2023 ($3.78 Mil) to Dec. 2024 ($0.00 Mil) but then
increased
from Dec. 2024 ($0.00 Mil) to Dec. 2025 ($0.00 Mil).
Eloxx Pharmaceuticals's annual market cap
declined
from Dec. 2023 ($3.78 Mil) to Dec. 2024 ($0.00 Mil) but then
increased
from Dec. 2024 ($0.00 Mil) to Dec. 2025 ($0.00 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Eloxx Pharmaceuticals's Enterprise Value for Today is $37.61 Mil.
Eloxx Pharmaceuticals (NAS:ELOX) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Eloxx Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eloxx Pharmaceuticals Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Eloxx Pharmaceuticals's Market Cap distribution charts can be found below:
* The bar in red indicates where Eloxx Pharmaceuticals's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Eloxx Pharmaceuticals's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eloxx Pharmaceuticals (ELOX) has a Market Cap of $41.39 Mil as of Jun. 27, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Eloxx Pharmaceuticals and its competitors. According to the industry distribution chart, Eloxx Pharmaceuticals ranks #960 out of 1431 companies in the Biotechnology industry, placing it in the top 67.1%.
Is Eloxx Pharmaceuticals' Market Cap too high?
Eloxx Pharmaceuticals' current Market Cap is $41.39 Mil. The Biotechnology industry median Market Cap is 113.83. Eloxx Pharmaceuticals' value of $41.39 Mil is 63.6% below this industry median. Based on the distribution chart, Eloxx Pharmaceuticals ranks #960 out of 1431 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Eloxx Pharmaceuticals has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Eloxx Pharmaceuticals' Market Cap compare to CPMV and OGEN?
According to the Biotechnology industry distribution chart, Eloxx Pharmaceuticals ranks #960 out of 1431 companies for Market Cap. This places Eloxx Pharmaceuticals in the lower half of its industry. The industry median Market Cap is 113.83. Eloxx Pharmaceuticals' value of $41.39 Mil is 63.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 113.83, based on 1,431 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eloxx Pharmaceuticals's current Market Cap of $41.39 Mil is 63.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Eloxx Pharmaceuticals and its competitors. For the Biotechnology industry, the median Market Cap is 113.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eloxx Pharmaceuticals's current Market Cap is $41.39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eloxx Pharmaceuticals stock overvalued right now?
Eloxx Pharmaceuticals (ELOX) has a current Market Cap of $41.39 Mil. The current Market Cap is $41.39 Mil and 63.6% below the Biotechnology industry median of 113.83. Eloxx Pharmaceuticals' overall GF Score™ is 17/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Eloxx Pharmaceuticals (ELOX), the current Market Cap is $41.39 Mil as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.
17GF Score
Get the complete analysis for ELOX
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ELOX has been successfully added to your 
